Feb 1, 2021
An observational cohort study performed to describe
characteristics and outcomes of hematopoietic stem-cell
transplantation (HSCT) recipients after developing COVID-19
Season-3 is here! Tune in for InpharmD's podcast series, as we bring you clinical summaries and critiques of the most trending medical literature on the market.
Having trouble logging in?